Bangladesh vs Pakistan: The number of people with susceptibility test result for rifampicin
Bangladesh
82,924
in 2021
Pakistan
125,823
in 2021
Bangladesh rank
7th
Pakistan rank
4th
The number of people with susceptibility test result for rifampicin over time
- Bangladesh
- Pakistan
How they compare
Pakistan currently reports 125,823 against 82,924 in Bangladesh, a difference of 42,899.
That makes Pakistan's figure about 1.5 times Bangladesh's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Bangladesh ahead.
Bangladesh ranks 7th and Pakistan ranks 4th of 155 countries.
Pakistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bangladesh | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 39,340 | 55,256 | 15,916 | Pakistan |
| 2020s | 65,400 | 99,270 | 33,870 | Pakistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bangladesh or Pakistan?
- Pakistan, at 125,823 against 82,924 in Bangladesh as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bangladesh and Pakistan?
- 42,899, with Pakistan ahead.
- How many years of comparable data are there for Bangladesh and Pakistan?
- 5 years are reported by both, from 2017 to 2021.
- How do Bangladesh and Pakistan rank globally for the number of people with susceptibility test result for rifampicin?
- Bangladesh ranks 7th and Pakistan ranks 4th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.